Literature DB >> 28794905

Further Clinical Delineation of the MEF2C Haploinsufficiency Syndrome: Report on New Cases and Literature Review of Severe Neurodevelopmental Disorders Presenting with Seizures, Absent Speech, and Involuntary Movements.

Irena Vrečar1,2, Josie Innes1, Elizabeth A Jones1,3, Helen Kingston1,3, William Reardon4, Bronwyn Kerr1,3, Jill Clayton-Smith1,3, Sofia Douzgou1,3.   

Abstract

Mutations in the MEF2C ( myocyte enhancer factor 2 ) gene have been established as a cause for an intellectual disability syndrome presenting with seizures, absence of speech, stereotypic movements, hypotonia, and limited ambulation. Phenotypic overlap with Rett's and Angelman's syndromes has been noted. Following the first reports of 5q14.3q15 microdeletions encompassing the MEF2C gene, further cases with point mutations and partial gene deletions of the MEF2C gene have been described. We present the clinical phenotype of our cohort of six patients with MEF2C mutations and compare our findings with previously reported patients as well as with a growing number of genetic conditions presenting with a severe neurodevelopmental, Rett-like, phenotype. We aim to add to the current knowledge of the natural history of the "MEF2C haploinsufficiency syndrome" as well as of the differential diagnosis, clinical management, and genetic counseling in this diagnostically challenging group of patients.

Entities:  

Keywords:  MEF2C; epilepsy; intellectual disability; involuntary movements; speech delay

Year:  2017        PMID: 28794905      PMCID: PMC5548525          DOI: 10.1055/s-0037-1601335

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  45 in total

1.  Late-onset gain of skills and peculiar jugular pit in an 11-year-old girl with 5q14.3 microdeletion including MEF2C.

Authors:  Siren Berland; Gunnar Houge
Journal:  Clin Dysmorphol       Date:  2010-10       Impact factor: 0.816

2.  Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.

Authors:  Markus Zweier; Anne Gregor; Christiane Zweier; Hartmut Engels; Heinrich Sticht; Eva Wohlleber; Emilia K Bijlsma; Susan E Holder; Martin Zenker; Eva Rossier; Ute Grasshoff; Diana S Johnson; Lisa Robertson; Helen V Firth; Arif B Ekici; André Reis; Anita Rauch
Journal:  Hum Mutat       Date:  2010-06       Impact factor: 4.878

3.  Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C.

Authors:  Beata A Nowakowska; Ewa Obersztyn; Krystyna Szymańska; Monika Bekiesińska-Figatowska; Zhilian Xia; Christian B Ricks; Ewa Bocian; David W Stockton; Krzysztof Szczałuba; Magdalena Nawara; Ankita Patel; Daryl A Scott; Sau Wai Cheung; Timothy P Bohan; Paweł Stankiewicz
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-07       Impact factor: 3.568

4.  The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy.

Authors:  Stephanie Fehr; Meredith Wilson; Jenny Downs; Simon Williams; Alessandra Murgia; Stefano Sartori; Marilena Vecchi; Gladys Ho; Roberta Polli; Stavroula Psoni; Xinhua Bao; Nick de Klerk; Helen Leonard; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2012-08-08       Impact factor: 4.246

Review 5.  Adenylosuccinate lyase deficiency.

Authors:  Erin K Spiegel; Roberta F Colman; David Patterson
Journal:  Mol Genet Metab       Date:  2006-07-12       Impact factor: 4.797

6.  Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2.

Authors:  Kevin A Strauss; Erik G Puffenberger; Matthew J Huentelman; Steven Gottlieb; Seth E Dobrin; Jennifer M Parod; Dietrich A Stephan; D Holmes Morton
Journal:  N Engl J Med       Date:  2006-03-30       Impact factor: 91.245

7.  Periventricular heterotopia, mental retardation, and epilepsy associated with 5q14.3-q15 deletion.

Authors:  C Cardoso; A Boys; E Parrini; C Mignon-Ravix; J M McMahon; S Khantane; E Bertini; E Pallesi; C Missirian; O Zuffardi; F Novara; L Villard; S Giglio; B Chabrol; H R Slater; A Moncla; I E Scheffer; R Guerrini
Journal:  Neurology       Date:  2008-12-10       Impact factor: 9.910

8.  Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome.

Authors:  Heather E Olson; Dimira Tambunan; Christopher LaCoursiere; Marti Goldenberg; Rebecca Pinsky; Emilie Martin; Eugenia Ho; Omar Khwaja; Walter E Kaufmann; Annapurna Poduri
Journal:  Am J Med Genet A       Date:  2015-04-25       Impact factor: 2.802

Review 9.  MEF2C haploinsufficiency syndrome: Report of a new MEF2C mutation and review.

Authors:  Helena Rocha; Mafalda Sampaio; Ruben Rocha; Susana Fernandes; Miguel Leão
Journal:  Eur J Med Genet       Date:  2016-05-31       Impact factor: 2.708

10.  The transcription factor MEF2C is required for craniofacial development.

Authors:  Michael P Verzi; Pooja Agarwal; Courtney Brown; David J McCulley; John J Schwarz; Brian L Black
Journal:  Dev Cell       Date:  2007-04       Impact factor: 12.270

View more
  17 in total

Review 1.  Emerging roles for MEF2 in brain development and mental disorders.

Authors:  Ahlem Assali; Adam J Harrington; Christopher W Cowan
Journal:  Curr Opin Neurobiol       Date:  2019-05-23       Impact factor: 6.627

2.  MEF2C gene variations are associated with ADHD in the Chinese Han population: a case-control study.

Authors:  Xihang Fu; Ting Yao; Xinzhen Chen; Huiru Li; Jing Wu
Journal:  J Neural Transm (Vienna)       Date:  2022-03-31       Impact factor: 3.850

3.  Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice.

Authors:  Sarah E Sinnett; Emily Boyle; Christopher Lyons; Steven J Gray
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

4.  Identification of a novel mutation in MEF2C gene in an atypical patient with frontotemporal lobar degeneration.

Authors:  Andreia Adrião; Isabel Santana; Carolina Ribeiro; M Leonor Cancela; Natércia Conceição; Manuela Grazina
Journal:  Neurol Sci       Date:  2021-05-17       Impact factor: 3.307

5.  Non-coding region variants upstream of MEF2C cause severe developmental disorder through three distinct loss-of-function mechanisms.

Authors:  Caroline F Wright; Nicholas M Quaife; Laura Ramos-Hernández; Petr Danecek; Matteo P Ferla; Kaitlin E Samocha; Joanna Kaplanis; Eugene J Gardner; Ruth Y Eberhardt; Katherine R Chao; Konrad J Karczewski; Joannella Morales; Giuseppe Gallone; Meena Balasubramanian; Siddharth Banka; Lianne Gompertz; Bronwyn Kerr; Amelia Kirby; Sally A Lynch; Jenny E V Morton; Hailey Pinz; Francis H Sansbury; Helen Stewart; Britton D Zuccarelli; Stuart A Cook; Jenny C Taylor; Jane Juusola; Kyle Retterer; Helen V Firth; Matthew E Hurles; Enrique Lara-Pezzi; Paul J R Barton; Nicola Whiffin
Journal:  Am J Hum Genet       Date:  2021-05-21       Impact factor: 11.025

6.  Genotypes and Phenotypes of MEF2C Haploinsufficiency Syndrome: New Cases and Novel Point Mutations.

Authors:  Lin Wan; Xinting Liu; Linyan Hu; Huimin Chen; Yulin Sun; Zhichao Li; Zhenfang Wang; Zhi Lin; Liping Zou; Guang Yang
Journal:  Front Pediatr       Date:  2021-05-13       Impact factor: 3.418

7.  Drug repositioning in epilepsy reveals novel antiseizure candidates.

Authors:  Leo Brueggeman; Morgan L Sturgeon; Russell M Martin; Andrew J Grossbach; Yasunori Nagahama; Angela Zhang; Mathew A Howard; Hiroto Kawasaki; Shu Wu; Robert A Cornell; Jacob J Michaelson; Alexander G Bassuk
Journal:  Ann Clin Transl Neurol       Date:  2018-12-11       Impact factor: 4.511

8.  MEF2C Hypofunction in Neuronal and Neuroimmune Populations Produces MEF2C Haploinsufficiency Syndrome-like Behaviors in Mice.

Authors:  Adam J Harrington; Catherine M Bridges; Stefano Berto; Kayla Blankenship; Jennifer Y Cho; Ahlem Assali; Benjamin M Siemsen; Hannah W Moore; Evgeny Tsvetkov; Acadia Thielking; Genevieve Konopka; David B Everman; Michael D Scofield; Steven A Skinner; Christopher W Cowan
Journal:  Biol Psychiatry       Date:  2020-03-31       Impact factor: 13.382

9.  Novel MEF2C point mutations in Chinese patients with Rett (-like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation.

Authors:  Jiaping Wang; Qingping Zhang; Yan Chen; Shujie Yu; Xiru Wu; Xinhua Bao; Yongxin Wen
Journal:  BMC Med Genet       Date:  2018-10-30       Impact factor: 2.103

10.  A neuronal enhancer network upstream of MEF2C is compromised in patients with Rett-like characteristics.

Authors:  Eva D'haene; Reut Bar-Yaacov; Inbar Bariah; Lies Vantomme; Sien Van Loo; Francisco Avila Cobos; Karen Verboom; Reut Eshel; Rawan Alatawna; Björn Menten; Ramon Y Birnbaum; Sarah Vergult
Journal:  Hum Mol Genet       Date:  2019-03-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.